ESTRELLA IMMUNOPHARMA, INC. Public Float
ESTRELLA IMMUNOPHARMA, INC. (ESLA) had Public Float of $20.50 million as of 2026-03-12, per its 10-K/A filed 2026-04-30.
Financial Statements › Notes › Cover Page
dei:EntityPublicFloat · last filed 2026-04-30
- 2026-03-12: Entity Public Float $20.50M.
- 2024-07-01: Entity Public Float $39.97M; Entity Public Float as first filed $40.27M.
- 2022-06-30: Entity Public Float $58.50M.
- 2021-12-31: Entity Public Float $0.00.
| Period end | Entity Public Float | Entity Public Float as first filed |
|---|---|---|
| 2026-03-12 | $20.50M 10-K/A · filed 2026-04-30 | |
| 2024-07-01 | $39.97M 10-KT · filed 2025-03-25 | $40.27M 10-K · filed 2024-09-27 |
| 2022-06-30 | $58.50M 10-K · filed 2023-03-14 | |
| 2021-12-31 | $0.00 10-K · filed 2022-03-29 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Jasper Therapeutics, Inc. (JSPR) | United States | $0.020B | -0.37 |
| BioCardia, Inc. (BCDA) | United States | $0.016B | |
| DYADIC INTERNATIONAL INC (DYAI) | United States | $0.016B | |
| Passage BIO, Inc. (PASG) | United States | $0.015B | -0.43 |
| Pluri Inc. (PLUR) | $0.014B | ||
| INTENSITY THERAPEUTICS, INC. (INTS) | United States | $0.013B | -1.08 |
| BRAINSTORM CELL THERAPEUTICS INC. (BCLI) | United States | $0.013B | -1.05 |
| IN8BIO, INC. (INAB) | United States | $0.012B | -0.76 |
| Senti Biosciences Holdings, Inc. (SNTI) | United States | $0.011B | -0.70 |
| CEL SCI CORP (CVM) | United States | $0.030B | -0.81 |